Loaʻa iā mākou kahi hui maikaʻi loa e hana i nā nīnau mai nā mea kūʻai aku. ʻO kā mākou pahuhopu "100% ka hauʻoli o ka mea kūʻai aku e kā mākou hopena kiʻekiʻe - maikaʻi, helu a me kā mākou lawelawe hui" a hauʻoli i kahi kaulana nui i waena o nā mea kūʻai. Me nā ʻoihana he nui, e hāʻawi mākou i kahi ʻano ākea o ka protein-binding,kime kohu hana, Puke Tissue maka, beagle Canine PBMC kit, cyp2e1 kime. Hoʻokipa mākou i nā mea kūʻai hou a me nā mea kahiko mai nāʻano likeʻole e hoʻokaʻaʻike mai iā mākou no nā pilinaʻoihana e hiki mai ana a me ka holomua like! Nui nā mea kūʻai i lilo i mau hoaaloha ma hope o ka launa pū ʻana me mākou. Inā loaʻa iā ʻoe ka koi no kekahi o kā mākou waiwai, e hōʻoia ʻoe e kelepona mai iā mākou i kēia manawa. Ke kali nei mākou i ka lohe koke ʻana mai iā ʻoe.Hepatocyte cell culture media kit, rabbit vitreous humor kit, pahu hoʻohenehene vitreous iole, puʻupuʻu hakina S9.
Ma ke kahua ākea o ka lāʻau lapaʻau a me ka ʻike ʻana i ka lāʻau, ua hoʻokumu ʻo IPHASE i kahi pūʻulu o nā kit biomicrosomes kiʻekiʻe-performance, me ka kit microsomes ate, kit microsomes intestinal a me nā micros intestinal.
ʻO C57BL/6, i kapa pinepine ʻia ʻo "C57 ʻeleʻele 6", "C57", a i ʻole "ʻeleʻele 6" (ka pōkole maʻamau B6), he ʻano maʻamau maʻamau o ka ʻiole laboratory. Hoʻohana nui ʻia ʻo ia ma ke ʻano he ʻiole transgenic i ka hoʻāʻo genetic e hoʻohālike i nā hemahema genetic kanaka.
ʻO ka hoʻokaʻawale ʻana o Peripheral Blood Mononuclear Cells (PBMC) he hana koʻikoʻi i ka noiʻi biomedical a me nā noi lapaʻau. Loaʻa i kēia mau pūnaewele nā lymphocytes (e laʻa, T cell, B cell, NK cell) a
Ma muli o ka emi ʻana o ka hana o ka enzyme metabolizing i ka lāʻau me ka hoʻolōʻihi ʻia o ka manawa incubation in vitro, loaʻa i nā hiʻohiʻona kuʻuna in vitro metabolism nā palena e like me ka manawa incubation pōkole.
Introduction He mea koʻikoʻi nā cell T o ka ʻōnaehana pale, e pāʻani ana i kahi kuleana koʻikoʻi i ka ʻike ʻana a me ka hakakā ʻana i nā pathogens. ʻO ke kaʻina hana o ka T cell activation he mea paʻakikī, multi-step mechanis
ʻO Antibody-Drug Conjugate (ADC) kahi ʻano hou o ka lāʻau biotechnology e hui pū ana i nā pūhui therapeutic mole liʻiliʻi i ka huli ʻana i nā antibodies / ʻāpana antibody e nā loulou.
Mālama ka hui i ka manaʻo hana "hoʻokele ʻepekema, kiʻekiʻe kiʻekiʻe a me ka pono primacy, mea kūʻai kiʻekiʻe", ua mālama mau mākou i ka hui ʻoihana. E hana pū me ʻoe, ua maʻalahi mākou!
He nui nā koho i hoʻomākaukau ʻia e kēia hui e koho ai a hiki nō hoʻi ke hana i ka papahana hou e like me kā mākou makemake, he mea maikaʻi loa ia e hoʻokō i kā mākou pono.